2017 Lynn Sage Breast Cancer Symposium

Advertisement

Advertisement



Oct
17
Today In Oncology
FDA Approves Talazoparib for Deleterious Germline BRCA-Mutated HER2-Negative Locally Advanced or Metastatic Breast Cancer
Study Finds Deep Learning Can Distinguish Recalled-Benign Mammogram Images From Malignant and Negative Cases
FDA Accepts New Drug Application, Grants Priority Review to Selinexor for Pentarefractory Multiple Myeloma
Small Study of Neoadjuvant Combination Checkpoint Blockade in High-Risk Stage III Melanoma
Opioid Use Following Video-Assisted Thoracoscopic Surgery or Open Resection in Early-Stage Lung Cancer
View More 
;
Advertisement
Most Read Stories
FDA Approves Expanded Use of Gardasil 9 to Include Individuals Aged 27 to 45
ASCO 2017: STAMPEDE Trial: Adding Abiraterone to Standard Treatment Improves Survival in Advanced Prostate Cancer
An Invitation to Be Quiet No Longer
Cognitive Impairment in Patients With Breast Cancer Treated With Chemotherapy
Results From ECHELON-2: Brentuximab Vedotin in CD30-Expressing Peripheral T-Cell Lymphoma
View More 
Most Viewed Videos
Jerald P. Radich, MD, on Chronic-Phase CML: Optimizing Tyrosine Kinase Inhibitor Therapy
Gabriel N. Hortobagyi, MD, on Breast Cancer Staging: New and Important Changes
Simron Singh, MD, MPH, on Patient-Centered Care: Measuring Experience
Ursula A. Matulonis, MD, and Daniel J. Margul, MD, PhD, on Cervical Cancer and Minimally Invasive Surgery
Fumiko Ladd Chino, MD, on Opioid-Associated Deaths in Patients With Cancer
View More 
© 2018 HSP News Service, L.L.C.
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.